Free Trial
NASDAQ:MOTS

Motus GI (MOTS) Stock Price, News & Analysis

Motus GI logo
$0.0002 0.00 (0.00%)
As of 10/9/2026

About Motus GI Stock (NASDAQ:MOTS)

Advanced

Key Stats

Today's Range
$0.0002
▼
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.10
Volume
N/A
Average Volume
5,986 shs
Market Capitalization
$1.15 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Motus GI is a medical technology company focused on improving the effectiveness and efficiency of lower gastrointestinal endoscopy procedures. The company develops devices designed to address inadequate bowel preparation, which can limit visualization during colonoscopy and may require repeat procedures.

Its primary product is the Pure-Vu System, including the Pure-Vu EVS platform. The system is designed to integrate with a standard colonoscope and help physicians remove residual stool and fluid during the procedure, supporting visualization of the colon without relying solely on conventional bowel-preparation methods.

Motus GI has focused on the U.S. market and has pursued regulatory clearance and commercial adoption of its Pure-Vu technology among hospitals, ambulatory surgery centers and gastroenterology practices. The company was founded to develop technologies for gastrointestinal care and has conducted research and development activities in Israel while commercializing its products internationally.

AI Generated. May Contain Errors.

Receive MOTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MOTS Stock News Headlines

MOTS Motus GI Holdings, Inc. - Seeking Alpha
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
See More Headlines

MOTS Stock Analysis - Frequently Asked Questions

Motus GI's stock was trading at $0.0001 at the start of the year. Since then, MOTS shares have increased by 100.0% and is now trading at $0.0002.

Motus GI Holdings, Inc. (NASDAQ:MOTS) issued its earnings results on Friday, November, 12th. The company reported ($30.00) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($30.00). The company had revenue of $0.14 million for the quarter, compared to analysts' expectations of $0.12 million.

Motus GI's stock reverse split on Thursday, November 2nd 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Motus GI (MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Inovio Pharmaceuticals (INO), Matinas Biopharma (MTNB), NIO (NIO), Tesla (TSLA), Bionano Genomics (BNGO), Pfizer (PFE).

Company Calendar

Last Earnings
11/12/2021
Today
10/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:MOTS
CIK
1686850
Employees
15
Year Founded
2010

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$319 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.74 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
5,769,000
Free Float
5,749,000
Market Cap
$1.15 thousand
Optionable
Not Optionable
Beta
0.68

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MOTS) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners